Artivion Missed Expectations

Artivion (AORT) reported earnings of $0.06 per share on revenue of $98.98 million for the first quarter ended March 2025. The consensus earnings estimate was $0.12 per share on revenue of $95.00 million. The Earnings Whisper number was $0.13 per share. The company missed expectations by 53.85% while revenue grew 1.59% on a year-over-year basis.

The company said it expects 2025 revenue of $423.0 million to $435.0 million. The company's previous guidance was revenue of $420.0 million to $435.0 million and the current consensus revenue estimate is $426.65 million for the year ending December 31, 2025.

Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases.